Kennedy Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-31,140
Closed -$615K 772
2018
Q3
$615K Sell
31,140
-335
-1% -$6.62K 0.01% 675
2018
Q2
$999K Buy
+31,475
New +$999K 0.02% 667